Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Corcept Therapeutics Inc (NASDAQ: CORT) closed at $54.44 in the last session, up 1.23% from day before closing price of $53.78. In other words, the price has increased by $1.23 from its previous closing price. On the day, 0.68 million shares were traded. CORT stock price reached its highest trading level at $54.81 during the session, while it also had its lowest trading level at $53.3.
Ratios:
We take a closer look at CORT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.00. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 10 ’25 when Swisher Daniel N JR sold 2,200 shares for $50.54 per share. The transaction valued at 111,188 led to the insider holds 0 shares of the business.
Swisher Daniel N JR bought 2,200 shares of CORT for $111,188 on Jan 10 ’25. On Jan 02 ’25, another insider, Maduck Sean, who serves as the insider of the company, sold 20,000 shares for $50.39 each. As a result, the insider received 1,007,800 and left with 85,318 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 5703950848 and an Enterprise Value of 5331984896. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.30, and their Forward P/E ratio for the next fiscal year is 28.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.07 while its Price-to-Book (P/B) ratio in mrq is 8.92. Its current Enterprise Value per Revenue stands at 8.483 whereas that against EBITDA is 37.006.
Stock Price History:
The Beta on a monthly basis for CORT is 0.56, which has changed by 1.2293203 over the last 52 weeks, in comparison to a change of 0.22677135 over the same period for the S&P500. Over the past 52 weeks, CORT has reached a high of $62.22, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is -0.75%, while the 200-Day Moving Average is calculated to be 38.81%.
Shares Statistics:
According to the various share statistics, CORT traded on average about 959.41K shares per day over the past 3-months and 737650 shares per day over the past 10 days. A total of 104.70M shares are outstanding, with a floating share count of 90.25M. Insiders hold about 13.87% of the company’s shares, while institutions hold 82.26% stake in the company. Shares short for CORT as of 1735603200 were 15958163 with a Short Ratio of 16.63, compared to 1732838400 on 17051615. Therefore, it implies a Short% of Shares Outstanding of 15958163 and a Short% of Float of 21.39.
